Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Assets: 2019-2025

Historic Return on Assets for Arcturus Therapeutics Holdings (ARCT) over the last 6 years, with Sep 2025 value amounting to -0.23%.

  • Arcturus Therapeutics Holdings' Return on Assets fell 6.00% to -0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.23%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of -0.21% for FY2024, which is 14.00% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Return on Assets stood at -0.23% for Q3 2025, which was down 20.14% from -0.19% recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Return on Assets ranged from a high of 0.24% in Q1 2023 and a low of -0.53% during Q1 2022.
  • Moreover, its 3-year median value for Return on Assets was -0.18% (2024), whereas its average is -0.08%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 78bps in 2023, then plummeted by 50bps in 2024.
  • Arcturus Therapeutics Holdings' Return on Assets (Quarterly) stood at -0.49% in 2021, then soared by 52bps to 0.03% in 2022, then fell by 10bps to -0.07% in 2023, then declined by 16bps to -0.23% in 2024, then declined by 6bps to -0.23% in 2025.
  • Its last three reported values are -0.23% in Q3 2025, -0.19% for Q2 2025, and -0.20% during Q1 2025.